These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15723986)

  • 1. Trafficking of the membrane type-1 matrix metalloproteinase in ischemia and reperfusion: relation to interstitial membrane type-1 matrix metalloproteinase activity.
    Deschamps AM; Yarbrough WM; Squires CE; Allen RA; McClister DM; Dowdy KB; McLean JE; Mingoia JT; Sample JA; Mukherjee R; Spinale FG
    Circulation; 2005 Mar; 111(9):1166-74. PubMed ID: 15723986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
    Jo M; Thomas LE; Wheeler SE; Curry TE
    Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
    González AA; Segura AM; Horiba K; Qian S; Yu ZX; Stetler-Stevenson W; Willerson JT; McAllister HA; Ferrans VJ
    Hum Pathol; 2002 Dec; 33(12):1158-64. PubMed ID: 12514782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transmembrane domain is essential for the microtubular trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP).
    Remacle AG; Rozanov DV; Baciu PC; Chekanov AV; Golubkov VS; Strongin AY
    J Cell Sci; 2005 Nov; 118(Pt 21):4975-84. PubMed ID: 16219679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stretch-induced membrane type matrix metalloproteinase and tissue plasminogen activator in cardiac fibroblast cells.
    Tyagi SC; Lewis K; Pikes D; Marcello A; Mujumdar VS; Smiley LM; Moore CK
    J Cell Physiol; 1998 Aug; 176(2):374-82. PubMed ID: 9648925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
    Inaki N; Tsunezuka Y; Kawakami K; Sato H; Takino T; Oda M; Watanabe G
    J Heart Lung Transplant; 2004 Feb; 23(2):218-27. PubMed ID: 14761770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential membrane type 1 matrix metalloproteinase substrate processing with ischemia-reperfusion: relationship to interstitial microRNA dynamics and myocardial function.
    Eckhouse SR; Akerman AW; Logdon CB; Oelsen JM; O'Quinn EC; Nadeau EK; Stroud RE; Mukherjee R; Jones JA; Spinale FG
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):267-275, 277.e1-4; discussion 275-7. PubMed ID: 23102905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial recovery from ischemia-reperfusion is compromised in the absence of tissue inhibitor of metalloproteinase 4.
    Takawale A; Fan D; Basu R; Shen M; Parajuli N; Wang W; Wang X; Oudit GY; Kassiri Z
    Circ Heart Fail; 2014 Jul; 7(4):652-62. PubMed ID: 24842912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
    Soini Y; Satta J; Määttä M; Autio-Harmainen H
    J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
    Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
    Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradigmatic identification of MMP-2 and MT1-MMP activation systems in cardiac fibroblasts cultured as a monolayer.
    Guo C; Jiang J; Elliott JM; Piacentini L
    J Cell Biochem; 2005 Feb; 94(3):446-59. PubMed ID: 15534869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential transcriptional activation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase by experimental deep venous thrombosis and thrombin.
    Dahi S; Lee JG; Lovett DH; Sarkar R
    J Vasc Surg; 2005 Sep; 42(3):539-45. PubMed ID: 16171603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury.
    Schulze CJ; Wang W; Suarez-Pinzon WL; Sawicka J; Sawicki G; Schulz R
    Circulation; 2003 May; 107(19):2487-92. PubMed ID: 12707244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats].
    Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion.
    Fert-Bober J; Leon H; Sawicka J; Basran RS; Devon RM; Schulz R; Sawicki G
    Basic Res Cardiol; 2008 Sep; 103(5):431-43. PubMed ID: 18512095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental hindlimb ischemia leads to neutrophil-mediated increases in gastrocnemius MMP-2 and -9 activity: a potential mechanism for ischemia induced MMP activation.
    Muhs BE; Gagne P; Plitas G; Shaw JP; Shamamian P
    J Surg Res; 2004 Apr; 117(2):249-54. PubMed ID: 15047130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
    Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig.
    Goetzenich A; Hatam N; Zernecke A; Weber C; Czarnotta T; Autschbach R; Christiansen S
    J Heart Lung Transplant; 2009 Oct; 28(10):1087-93. PubMed ID: 19782292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface.
    Remacle A; Murphy G; Roghi C
    J Cell Sci; 2003 Oct; 116(Pt 19):3905-16. PubMed ID: 12915589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.